Laman UtamaGNGBF • OTCMKTS
add
Getinge AB
Tutup sebelumnya
$24.48
Julat tahun
$18.54 - $24.48
Permodalan pasaran
56.07B SEK
Bilangan Purata
21.00
Nisbah P/E
-
Hasil dividen
-
Pertukaran utama
STO
Dalam berita
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (SEK) | Sep 2025info | Perubahan T/T |
|---|---|---|
Hasil | 8.23B | 4.52% |
Perbelanjaan pengendalian | 2.83B | 3.47% |
Pendapatan bersih | 566.00J | 28,200.00% |
Margin untung bersih | 6.88 | 22,833.33% |
Pendapatan bagi setiap syer | 2.42 | 8.04% |
EBITDA | 1.27B | 14.98% |
Kadar cukai berkesan | 27.09% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (SEK) | Sep 2025info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 2.85B | 27.04% |
Jumlah aset | 56.79B | -4.74% |
Jumlah liabiliti | 27.41B | -5.95% |
Jumlah ekuiti | 29.38B | — |
Syer tertunggak | 272.37J | — |
Harga kepada buku | 0.23 | — |
Pulangan pada aset | 4.35% | — |
Pulangan pada modal | 6.08% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (SEK) | Sep 2025info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | 566.00J | 28,200.00% |
Tunai daripada operasi | 1.08B | 59.41% |
Tunai daripada pelaburan | -292.00J | 90.61% |
Tunai daripada pembiayaan | 193.00J | -91.81% |
Perubahan bersih dalam tunai | 902.00J | 2,104.44% |
Aliran tunai bebas | 631.75J | -73.13% |
Perihal
Getinge AB is a publicly traded Swedish medical technology company. The company produces and distributes medical products and equipment for the healthcare and life sciences industries. The company is divided into three business areas: Life Science, Acute Care Therapies, and Surgical Workflows. The group employs approximately 12,000 people worldwide. The CEO of the company is Mattias Perjos, and the Chairman of the Board is Johan Malmquist. With a sales share of around 40%, the United States is by far the most important market for the company due to significantly higher prices and margins there. China and various Western European countries follow. Wikipedia
Diasaskan
1904
Tapak web
Pekerja
11,794
